SYHA1815 / CSPC Pharma  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
SYHA1815 / CSPC Pharma
ChiCTR2100046573: A Study to Investigate the Safety and Tolerability of SYHA1815 in Subjects with Unresectable Locally Advanced or Metastatic Solid Tumors

Recruiting
1
109
 
SYHA1815 tablets ;SYHA1815 tablets
Jilin Provincial Tumor Hospital; Shanghai Runshi Pharmaceutical Technology Co., Ltd., self-funded
Unresectable Locally Advanced or Metastatic Solid Tumors
 
 

Download Options